Latest

UK drugmaker GSK lifts 2025 guidance despite US tariffs
UK drugmaker GSK lifts 2025 guidance despite US tariffs
Economy
by  AFP

British pharmaceutical group GSK on Wednesday raised its full-year outlook after strong sales growth in its third quarter, brushing off the potential impact of US tariffs. The drugmaker on Wednesday said it expects full-year revenue to increase between six and seven percent, compared with an earlier forecast of three to five percent.